The sirtuins in the pathogenesis of cancer

Clinical Epigenetics

Volumn 1, Issue 3-4, 2010, Pages 71-83

  Voelter Mahlknecht, Susanne ^a   Mahlknecht, Ulrich ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Aging.; Calorie restriction.; Cancer.; Histone deacetylases.; SIRT1.; SIRT2.; SIRT3.; SIRT4.; SIRT5.; SIRT6.; SIRT7; Sirtuins.

Indexed keywords

SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7;

AGING; CALORIC RESTRICTION; CARCINOGENESIS; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW;

EID: 79952361402     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1007/s13148-010-0008-0     Document Type: Review

References (124)

1. Ahuja N, Schwer B, Carobbio S, Waltregny D, North BJ, Castronovo V, Maechler P, Verdin E (2007) Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem 282:33583-33592 (Pubitemid 350159524)
2. Allison SJ, Milner J (2007) SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways. Cell Cycle 6:2669-2677 (Pubitemid 350224051)
3. Anantharaman V, Aravind L (2008) Analysis of DBC1 and its homologs suggests a potential mechanism for regulation of sirtuin domain deacetylases by NAD metabolites. Cell Cycle 7:1467-1472 (Pubitemid 351872586)
4. Araki T, Sasaki Y, Milbrandt J (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305:1010-1013 (Pubitemid 39071777)
5. Ashraf N, Zino S, Macintyre A, Kingsmore D, Payne AP, George WD, Shiels PG (2006) Altered sirtuin expression is associated with node-positive breast cancer. Br J Cancer 95:1056-1061 (Pubitemid 44606833)
6. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342 (Pubitemid 44764104)
7. Bellizzi D, Rose G, Cavalcante P, Covello G, Dato S, De Rango F, Greco V, Maggiolini M, Feraco E, Mari V, Franceschi C, Passarino G, De Benedictis G (2005) A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85:258-263 (Pubitemid 40164791)
8. Bordone L, Cohen D, Robinson A, Motta MC, van Veen E, Czopik A, Steele AD, Crowe H, Marmor S, Luo J, Gu W, Guarente L (2007) SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 6:759-767 (Pubitemid 350131044)
9. Borra MT, Smith BC, Denu JM (2005) Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 280:17187-17195 (Pubitemid 41389185)
10. Bradbury CA, Khanim FL, Hayden R, Bunce CM, White DA, Drayson MT, Craddock C, Turner BM (2005) Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia 19:1751-1759 (Pubitemid 41486152)
11. Brooks CL, Gu W (2008) p53 activation: A case against Sir. Cancer Cell 13:377-378 (Pubitemid 351609448)
12. Brooks CL, Gu W (2009) How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 9:123-128
13. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011-2015 (Pubitemid 38393275)
14. Chen D, Steele AD, Lindquist S, Guarente L (2005) Increase in activity during calorie restriction requires Sirt1. Science 310:1641 (Pubitemid 41780779)
15. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305:390-392 (Pubitemid 38938153)
16. Das C, Lucia MS, Hansen KC, Tyler JK (2009) CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 459:113-117
17. Deng CX (2009) SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 5:147-152
18. Dransfeld CL, Alborzinia H, Wolfl S, Mahlknecht U (2010) SIRT3 SNPs validation in 640 individuals, functional analyses and new insights into SIRT3 stability. Int J Oncol 36:955-960
19. Engel N, Mahlknecht U (2008) Aging and anti-aging: Unexpected side effects of everyday medication through sirtuin1 modulation. Int J Mol Med 21:223-232 (Pubitemid 351222856)
20. Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, Campbell J, Bhimavarapu A, Luikenhuis S, de Cabo R, Fuchs C, Hahn WC, Guarente LP, Sinclair DA (2008) The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS ONE 3:e2020
21. Ford J, Jiang M, Milner J (2005) Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res 65:10457-10463 (Pubitemid 41743740)
22. Ford E, Voit R, Liszt G, Magin C, Grummt I, Guarente L (2006) Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev 20:1075-1080
23. Fraga MF, Esteller M (2007) Epigenetics and aging: The targets and the marks. Trends Genet 23:413-418 (Pubitemid 47088010)
24. Frye RA (1999) Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun 260:273-279 (Pubitemid 29351819)
25. Frye RA (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 273:793-798 (Pubitemid 30599063)
26. Frye R (2002) "SIRT8" expressed in thyroid cancer is actually SIRT7. Br J Cancer 87:1479 (Pubitemid 36044326)
27. Fu M, Liu M, Sauve AA, Jiao X, Zhang X, Wu X, Powell MJ, Yang T, Gu W, Avantaggiati ML, Pattabiraman N, Pestell TG, Wang F, Quong AA, Wang C, Pestell RG (2006) Hormonal control of androgen receptor function through SIRT1. Mol Cell Biol 26:8122-8135 (Pubitemid 44631010)
28. Garske AL, Smith BC, Denu JM (2007) Linking SIRT2 to Parkinson's disease. ACS Chem Biol 2:529-532 (Pubitemid 350011322)
29. Gruber J, Schaffer S, Halliwell B (2008) The mitochondrial free radical theory of ageing-where do we stand? Front Biosci 13:6554-6579
30. Guarente L, Picard F (2005) Calorie restriction-the SIR2 connection. Cell 120:473-482
31. Hadley EC, Lakatta EG, Morrison-Bogorad M, Warner HR, Hodes RJ (2005) The future of aging therapies. Cell 120:557-567 (Pubitemid 40269769)
32. Haigis MC, Sinclair DA (2010) Mammalian sirtuins: Biological insights and disease relevance. Annu Rev Pathol 5:253-295
33. Haigis MC, Mostoslavsky R, Haigis KM, Fahie K, Christodoulou DC, Murphy AJ, Valenzuela DM, Yancopoulos GD, Karow M, Blander G,Wolberger C, Prolla TA,Weindruch R, AltFW,Guarente L (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126:941-954 (Pubitemid 44321935)
34. Hallows WC, Lee S, Denu JM (2006) Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci U S A 103:10230-10235 (Pubitemid 44051149)
35. Hallows WC, Albaugh BN, Denu JM (2008) Where in the cell is SIRT3? Functional localization of an NAD+-dependent protein deacetylase. Biochem J 411:e11-e13
36. Heilbronn LK, Ravussin E (2003) Calorie restriction and aging: Review of the literature and implications for studies in humans. Am J Clin Nutr 78:361-369 (Pubitemid 39663500)
37. Heltweg B, Gatbonton T, Schuler AD, Posakony J, Li H, Goehle S, Kollipara R, Depinho RA, Gu Y, Simon JA, Bedalov A (2006) Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res 66:4368-4377
38. Hida Y, Kubo Y, Murao K, Arase S (2007) Strong expression of a longevity-related protein, SIRT1, in Bowen's disease. Arch Dermatol Res 299:103-106 (Pubitemid 46669407)
39. Hiratsuka M, Inoue T, Toda T, Kimura N, Shirayoshi Y, Kamitani H, Watanabe T, Ohama E, Tahimic CG, Kurimasa A, Oshimura M (2003) Proteomics-based identification of differentially expressed genes in human gliomas: Down-regulation of SIRT2 gene. Biochem Biophys Res Commun 309:558-566 (Pubitemid 37083288)
40. Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, Stevens RD, Li Y, Saha AK, Ruderman NB, Bain JR, Newgard CB, Farese RV Jr, Alt FW, Kahn CR, Verdin E (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464:121-125
41. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191-196 (Pubitemid 37150899)
42. Huang J, Gan Q, Han L, Li J, Zhang H, Sun Y, Zhang Z, Tong T (2008) SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS ONE 3:e1710
43. Huffman DM, Grizzle WE, Bamman MM, Kim JS, Eltoum IA, Elgavish A, Nagy TR (2007) SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res 67:6612-6618 (Pubitemid 47105506)
44. Imai S, Guarente L (2010) Ten years of NAD-dependent SIR2 family deacetylases: Implications for metabolic diseases. Trends Pharmacol Sci 31:212-220
45. Imai S, Armstrong CM, Kaeberlein M, Guarente L (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403:795-800 (Pubitemid 30111843)
46. Inoue T, Hiratsuka M, Osaki M, Oshimura M (2007a) The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle 6:1011-1018 (Pubitemid 46708571)
47. Inoue T, Hiratsuka M, Osaki M, Yamada H, Kishimoto I, Yamaguchi S, Nakano S, Katoh M, Ito H, Oshimura M (2007b) SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress. Oncogene 26:945-957
48. Inoue T, Nakayama Y, Yamada H, Li YC, Yamaguchi S, Osaki M, Kurimasa A, Hiratsuka M, Katoh M, Oshimura M (2009) SIRT2 downregulation confers resistance to microtubule inhibitors by prolonging chronic mitotic arrest. Cell Cycle 8:1279-1291
49. Jin L, Wei W, Jiang Y, Peng H, Cai J, Mao C, Dai H, Choy W, Bemis JE, Jirousek MR, Milne JC, Westphal CH, Perni RB (2009) Crystal structures of human SIRT3 displaying substrate-induced conformational changes. J Biol Chem 284:24394-24405
50. Jing E, Gesta S, Kahn CR (2007) SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab 6:105-114 (Pubitemid 47163621)
51. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428 (Pubitemid 34587077)
52. Jung-Hynes B, Nihal M, Zhong W, Ahmad N (2009) Role of sirtuin histone deacetylase SIRT1 in prostate cancer. a target for prostate cancer management via its inhibition? J Biol Chem 284:3823-3832
53. Katic M, Kahn CR (2005) The role of insulin and IGF-1 signaling in longevity. Cell Mol Life Sci 62:320-343 (Pubitemid 40379247)
54. Kealy RD, Lawler DF, Ballam JM, Mantz SL, Biery DN, Greeley EH, Lust G, Segre M, Smith GK, Stowe HD (2002) Effects of diet restriction on life span and age-related changes in dogs. J Am Vet Med Assoc 220:1315-1320 (Pubitemid 135697968)
55. Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J, Cheng T, Kho Y, Xiao H, Xiao L, Grishin NV, White M, Yang XJ, Zhao Y (2006) Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 23:607-618 (Pubitemid 44205490)
56. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair DA, Tsai LH (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26:3169-3179 (Pubitemid 47057498)
57. Kim JE, Chen J, Lou Z (2008) DBC1 is a negative regulator of SIRT1. Nature 451:583-586 (Pubitemid 351186264)
58. Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D (2010) SIRT3 is a mitochondrialocalized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17:41-52
59. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109-1122 (Pubitemid 44894520)
60. Lamming DW, Latorre-Esteves M, Medvedik O, Wong SN, Tsang FA, Wang C, Lin SJ, Sinclair DA (2005) HST2 mediates SIR2- independent life-span extension by calorie restriction. Science 309:1861-1864 (Pubitemid 41325097)
61. Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L, Sternglanz R (2000) The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci U S A 97:5807-5811 (Pubitemid 30367480)
62. Lane MA, Ball SS, Ingram DK, Cutler RG, Engel J, Read V, Roth GS (1995) Diet restriction in rhesus monkeys lowers fasting and glucose-stimulated glucoregulatory end points. Am J Physiol 268:E941-E948
63. Lane MA, Baer DJ, Rumpler WV, Weindruch R, Ingram DK, Tilmont EM, Cutler RG, Roth GS (1996) Calorie restriction lowers body temperature in rhesus monkeys, consistent with a postulated antiaging mechanism in rodents. Proc Natl Acad Sci U S A 93:4159-4164 (Pubitemid 26144257)
64. Lanza IR, Short DK, Short KR, Raghavakaimal S, Basu R, Joyner MJ, McConnell JP, Nair KS (2008) Endurance exercise as a countermeasure for aging. Diabetes 57:2933-2942
65. Lim CS (2006) SIRT1: Tumor promoter or tumor suppressor? Med Hypotheses 67:341-344
66. Liszt G, Ford E, Kurtev M, Guarente L (2005) Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem 280:21313-21320 (Pubitemid 40805693)
67. Liu Y, Dentin R, Chen D, Hedrick S, Ravnskjaer K, Schenk S, Milne J, Meyers DJ, Cole P, Yates J 3rd, Olefsky J, Guarente L, Montminy M (2008) A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 456:269-273
68. Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt FW (2005) DNA repair, genome stability, and aging. Cell 120:497-512 (Pubitemid 40269764)
69. Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, Yang Y, Chen Y, Hirschey MD, Bronson RT, Haigis M, Guarente LP, Farese RV Jr, Weissman S, Verdin E, Schwer B (2007) Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 27:8807-8814
70. Longo VD, Kennedy BK (2006) Sirtuins in aging and age-related disease. Cell 126:257-268 (Pubitemid 44092970)
71. Lopez-Lluch G, Irusta PM, Navas P, de Cabo R (2008) Mitochondrial biogenesis and healthy aging. Exp Gerontol 43:813-819
72. Love R (2005) Calorie restriction may be neuroprotective in AD and PD. Lancet Neurol 4:84
73. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107:137-148 (Pubitemid 33035941)
74. Ma W, Stafford LJ, Li D, Luo J, Li X, Ning G, Liu M (2007) GCIP/ CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis. J Cell Biochem 100:1376-1386 (Pubitemid 46515572)
75. Mahlknecht U, Hoelzer D (2000a) Histone acetylation modifiers in the pathogenesis of malignant disease. Mol Med 6:623-644
76. Mahlknecht U, Voelter-Mahlknecht S (2009a) Chromosomal characterization and localization of the NAD+-dependent histone deacetylase gene sirtuin 1 in the mouse. Int J Mol Med 23: 245-252
77. Mahlknecht U, Voelter-Mahlknecht S (2009b) Fluorescence in situ hybridization and chromosomal organization of the sirtuin 4 gene (Sirt4) in the mouse. Biochem Biophys Res Commun 382:685-690
78. Mahlknecht U, Ottmann OG, Hoelzer D (2000b) When the band begins to play: Histone acetylation caught in the crossfire of gene control. Mol Carcinog 27:268-271 (Pubitemid 30191996)
79. Mahlknecht U, Ho AD, Letzel S, Voelter-Mahlknecht S (2006a) Assignment of the NAD-dependent deacetylase sirtuin 5 gene (SIRT5) to human chromosome band 6p23 by in situ hybridization. Cytogenet Genome Res 112:208-212 (Pubitemid 43260745)
80. Mahlknecht U, Ho AD, Voelter-Mahlknecht S (2006b) Chromosomal organization and fluorescence in situ hybridization of the human sirtuin 6 gene. Int J Oncol 28:447-456
81. Masoro EJ (2000) Caloric restriction and aging: An update. Exp Gerontol 35:299-305 (Pubitemid 30314687)
82. Masoro EJ, Austad SN (1996) The evolution of the antiaging action of dietary restriction: A hypothesis. J Gerontol A Biol Sci Med Sci 51:B387-B391 (Pubitemid 26394063)
83. Mattison JA, Lane MA, Roth GS, Ingram DK (2003) Calorie restriction in rhesus monkeys. Exp Gerontol 38:35-46 (Pubitemid 36110497)
84. McCay CM, Crowell MF, Maynard LA (1989) The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition 5:155-171, discussion 172
85. Mei S, Ho AD, Mahlknecht U (2004) Role of histone deacetylase inhibitors in the treatment of cancer (review). Int J Oncol 25:1509-1519
86. Michan S, Sinclair D (2007) Sirtuins in mammals: Insights into their biological function. Biochem J 404:1-13 (Pubitemid 46788079)
87. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16:4623-4635 (Pubitemid 41416446)
88. Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, Cheung P, Kusumoto R, Kawahara TL, Barrett JC, Chang HY, Bohr VA, Ried T, Gozani O, Chua KF (2008) SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452:492-496 (Pubitemid 351450840)
89. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, Bemis JE, Xie R, Disch JS, Ng PY, Nunes JJ, Lynch AV, Yang H, Galonek H, Israelian K, Choy W, Iffland A, Lavu S, Medvedik O, Sinclair DA, Olefsky JM, Jirousek MR, Elliott PJ, Westphal CH (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450:712-716 (Pubitemid 350207685)
90. Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, Liu P, Mostoslavsky G, Franco S, Murphy MM, Mills KD, Patel P, Hsu JT, Hong AL, Ford E, Cheng HL, Kennedy C, Nunez N, Bronson R, Frendewey D, Auerbach W, Valenzuela D, Karow M, Hottiger MO, Hursting S, Barrett JC, Guarente L, Mulligan R, Demple B, Yancopoulos GD, Alt FW (2006) Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124:315-329 (Pubitemid 43121980)
91. Nakagawa T, Lomb DJ, Haigis MC, Guarente L (2009) SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137:560-570
92. Nie Y, Erion DM, Yuan Z, Dietrich M, Shulman GI, Horvath TL, Gao Q (2009) STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat Cell Biol 11:492-500
93. North BJ, Verdin E (2007) Mitotic regulation of SIRT2 by cyclindependent kinase 1-dependent phosphorylation. J Biol Chem 282:19546-19555 (Pubitemid 47100062)
94. North BJ, Marshall BL, Borra MT, Denu JM, Verdin E (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11:437-444 (Pubitemid 36293837)
95. Oberdoerffer P, Sinclair DA (2007) The role of nuclear architecture in genomic instability and ageing. Nat Rev Mol Cell Biol 8:692-702 (Pubitemid 47312825)
96. Oberdoerffer P, Michan S, McVay M, Mostoslavsky R, Vann J, Park SK, Hartlerode A, Stegmuller J, Hafner A, Loerch P, Wright SM, Mills KD, Bonni A, Yankner BA, Scully R, Prolla TA, Alt FW, Sinclair DA (2008) SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135:907-918
97. O'Hagan HM, Mohammad HP, Baylin SB (2008) Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet 4:e1000155
98. Ota H, Tokunaga E, Chang K, Hikasa M, Iijima K, Eto M, Kozaki K, Akishita M, Ouchi Y, Kaneki M (2006) Sirt1 inhibitor, sirtinol, induces senescence-like growth arrest with attenuated Ras- MAPK signaling in human cancer cells. Oncogene 25:176-185 (Pubitemid 43083679)
99. Ota H, Akishita M, Eto M, Iijima K, Kaneki M, Ouchi Y (2007) Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol 43:571-579 (Pubitemid 47615048)
100. Ouaissi M, Sielezneff I, Silvestre R, Sastre B, Bernard JP, Lafontaine JS, Payan MJ, Dahan L, Pirro N, Seitz JF, Mas E, Lombardo D, Ouaissi A (2008) High histone deacetylase 7 (HDAC7) expression is significantly associated with adenocarcinomas of the pancreas. Ann Surg Oncol 15:2318-2328
101. Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, Volk CB, Maxwell MM, Rochet JC, McLean PJ, Young AB, Abagyan R, Feany MB, Hyman BT, Kazantsev AG (2007) Sirtuin 2 inhibitors rescue alpha-synuclein- mediated toxicity in models of Parkinson's disease. Science 317:516-519 (Pubitemid 47196116)
102. Pinney DO, Stephens DF, Pope LS (1972) Lifetime effects of winter supplemental feed level and age at first parturition on range beef cows. J Anim Sci 34:1067-1074
103. Pruitt K, Zinn RL, Ohm JE, McGarvey KM, Kang SH, Watkins DN, Herman JG, Baylin SB (2006) Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet 2:e40
104. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434:113-118 (Pubitemid 40349395)
105. Rose G, Dato S, Altomare K, Bellizzi D, Garasto S, Greco V, Passarino G, Feraco E, Mari V, Barbi C, BonaFe M, Franceschi C, Tan Q, Boiko S, Yashin AI, De Benedictis G (2003) Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp Gerontol 38:1065-1070 (Pubitemid 37324417)
106. Roth GS (2005) Caloric restriction and caloric restriction mimetics: Current status and promise for the future. J Am Geriatr Soc 53: S280-S283 (Pubitemid 41783135)
107. Roth GS, Ingram DK, Lane MA (1995) Slowing ageing by caloric restriction. Nat Med 1:414-415
108. Roth GS, Mattison JA, Ottinger MA, Chachich ME, Lane MA, Ingram DK (2004) Aging in rhesus monkeys: Relevance to human health interventions. Science 305:1423-1426 (Pubitemid 39167653)
109. Roth GS, Lane MA, Ingram DK (2005) Caloric restriction mimetics: The next phase. Ann NY Acad Sci 1057:365-371 (Pubitemid 43211646)
110. Sasaki T, Maier B, Bartke A, Scrable H (2006) Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell 5:413-422 (Pubitemid 44322537)
111. Saunders LR, Verdin E (2007) Sirtuins: Critical regulators at the crossroads between cancer and aging. Oncogene 26:5489-5504 (Pubitemid 47255930)
112. Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CF, Steegborn C (2008) Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol 382: 790-801
113. Schuetz A, Min J, Antoshenko T, Wang CL, Allali-Hassani A, Dong A, Loppnau P, Vedadi M, Bochkarev A, Sternglanz R, Plotnikov AN (2007) Structural basis of inhibition of the human NAD+- dependent deacetylase SIRT5 by suramin. Structure 15:377-389 (Pubitemid 46366726)
114. Schwer B, Bunkenborg J, Verdin RO, Andersen JS, Verdin E (2006) Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci U S A 103:10224-10229 (Pubitemid 44051148)
115. Shi T, Wang F, Stieren E, Tong Q (2005) SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 280:13560-13567 (Pubitemid 40517248)
116. Sinclair DA (2005) Toward a unified theory of caloric restriction and longevity regulation. Mech Ageing Dev 126:987-1002 (Pubitemid 41033180)
117. Sommer M, Poliak N, Upadhyay S, Ratovitski E, Nelkin BD, Donehower LA, Sidransky D (2006) DeltaNp63alpha overexpression induces downregulation of Sirt1 and an accelerated aging phenotype in the mouse. Cell Cycle 5:2005-2011 (Pubitemid 44435308)
118. Stunkel W, Peh BK, Tan YC, Nayagam VM, Wang X, Salto-Tellez M, Ni B, Entzeroth M, Wood J (2007) Function of the SIRT1 protein deacetylase in cancer. Biotechnol J 2:1360-1368 (Pubitemid 350176266)
119. Tanner KG, Landry J, Sternglanz R, Denu JM (2000) Silent information regulator 2 family of NAD- dependent histone/ protein deacetylases generates a unique product, 1-O-acetyl- ADP-ribose. Proc Natl Acad Sci U S A 97:14178-14182 (Pubitemid 32016550)
120. Vakhrusheva O, Smolka C, Gajawada P, Kostin S, Boettger T, Kubin T, Braun T, Bober E (2008) Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res 102:703-710 (Pubitemid 351457857)
121. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107:149-159 (Pubitemid 33035942)
122. Vijg J, Maslov AY, Suh Y (2008) Aging: A sirtuin shake-up? Cell 135:797-798
123. Voelter-Mahlknecht S, Mahlknecht U (2003) Cloning and structural characterization of the human histone deacetylase 6 gene. Int J Mol Med 12:87-93
124. Voelter-Mahlknecht S, Mahlknecht U (2006) Cloning, chromosomal characterization and mapping of the NAD-dependent histone deacetylases gene sirtuin 1. Int J Mol Med 17:59-67